2ccPA

2ccPA · Orient Europharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 2ccPA, covering 2024-03-21 to 2024-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis [Phase 1, Phase 2]

See pricing